Mar 21, 2022 | Digital Pathology, International Laboratory News, Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Pathology, Laboratory Testing, Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing, Precision Medicine, Uncategorized
Decision is part of UK effort to diagnose 75% of all cancers at stage I or stage II by 2028 and demonstrates to pathologists that the technology used in liquid biopsy tests is improving at a fast pace Pathologists and medical laboratory scientists know that when it comes to liquid biopsy tests to detect cancer, there is plenty of both hope and hype. Nevertheless, following a successful pilot study at the Christie NHS Foundation Trust in Manchester, England, which ran from 2015-2021, the UK’s...
Aug 29, 2018 | Laboratory Pathology
Just eleven common tests and procedures blamed for 93% of low-value services and 89% of wasted spending Overuse of medical laboratory tests and diagnostic procedures has been a long-standing issue among pathologists and other healthcare providers. Now a Washington State healthcare watchdog organization has put a $282-million price tag on the cost of what it calls “wasteful” spending for “low-value” clinical laboratory tests and other procedures in a single year. A study by the nonprofit...
Sep 30, 2016 | Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing, Management & Operations
Test ordering and results interpretation can confuse the public says Dartmouth Institute, which is why some clinical laboratories limit the types of lab tests that people can request Giving consumers direct access to medical laboratory testing continues to be a subject of some controversy. One factor in this debate is Theranos, which brought much attention to direct access testing, followed by extensive news coverage in recent months of its problems with reporting accurate clinical laboratory...
